Michael Dresdner, MD
Obstetrics · South Orange, NJNPI 1962567172
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,091 of the $2,790 with a category attached, or 74.9%. It is spread thinly across 32 manufacturers, the largest accounting for just 22.7%.
Across 148 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exeltis, USA Inc.$633
- Celularity Inc.$616
- AbbVie$348
- Astellas Pharma US Inc$281
- Lupin Inc.$121
- Therapeuticsmd, Inc.$99
- plus $691 from 26 others
What the payments were for
- Speaking & faculty fees$60022%
- Food & beverage$2,09175%
- Education$994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exeltis, USA Inc. | 45 | $633 |
| Celularity Inc. | 3 | $616 |
| AbbVie(2 entities) | 26 | $348 |
| Astellas Pharma US Inc | 13 | $281 |
| Lupin Inc. | 9 | $121 |
| Therapeuticsmd, Inc. | 6 | $99 |
| Avion Pharmaceuticals | 4 | $57 |
| Mayne Pharma Commercial LLC | 4 | $55 |
| Scynexis, Inc. | 4 | $54 |
| Vertical Pharmaceuticals, LLC | 3 | $44 |
| Axonics, Inc. | 1 | $40 |
| Lilly USA, LLC | 2 | $37 |
| Hologic Sales And Service, LLC | 2 | $36 |
| Novo Nordisk | 2 | $33 |
| Pfizer | 2 | $31 |
| Mycovia Pharmaceuticals, Inc. | 2 | $28 |
| Dysis Medical, Inc. | 1 | $28 |
| BD | 2 | $26 |
| Evofem Biosciences, Inc. | 2 | $26 |
| Coopersurgical, Inc. | 2 | $26 |
| Mission Pharmacal Company | 1 | $21 |
| Organon | 2 | $21 |
| Bayer | 1 | $18 |
| Roche Diagnostics Corporation | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Minerva Surgical, Inc | 1 | $13 |
| Novum Pharma, LLC | 1 | $13 |
| Millicent US Inc | 1 | $12 |
| Amgen | 1 | $12 |
| Alydia Health | 1 | $1 |
How this compares
$2,790 in reported general payments places this provider in the 80th percentile of 31 obstetrics providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $130 |
| Fluconazole | 32 | $104 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in South Orange
- Marc SiegelSomers Point$6K
- Audrey TashjianLawrenceville$6K
- Oren KeiserLivingston$5K
- Susan PacanaFreehold$4K
- Ralph CifaldiHawthorne$3K
- Sherrilynn ParrishPennsauken$2K
- Shilpa ClottWarren$2K
- Anu ChakrabortyRed Bank$2K
- Richard StewartNew Brunswick$1K
- Kristen McCullenMount Laurel$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.